191 related articles for article (PubMed ID: 4402775)
1. Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine- -hydroxylase inhibitors.
Andén NE; Corrodi H; Fuxe K
J Pharm Pharmacol; 1972 Mar; 24(3):177-82. PubMed ID: 4402775
[No Abstract] [Full Text] [Related]
2. Regional disappearance of catecholamines formed from 14 C-tyrosine in rat brain: effect of synthesis inhibitors and of chlorpromazine.
Nybäck H
Acta Pharmacol Toxicol (Copenh); 1971; 30(5):372-84. PubMed ID: 4401187
[No Abstract] [Full Text] [Related]
3. Some problems encountered in attempting to estimate catecholamine turnover using lbbelled tyrosine.
Persson T; Waldeck B
J Pharm Pharmacol; 1970 Jul; 22(7):473-8. PubMed ID: 4395050
[No Abstract] [Full Text] [Related]
4. Importance of nervous impulse flow for the neuroleptic induced increase in amine turnover in central dopamine neurons.
Andén NE; Corrodi H; Fuxe K; Ungerstedt U
Eur J Pharmacol; 1971 Jul; 15(2):193-9. PubMed ID: 4341651
[No Abstract] [Full Text] [Related]
5. Comparison of the behavioral depressant effects of biogenic amine depleting and neuroleptic agents following various 6-hydroxydopamine treatments.
Cooper BR; Grant LD; Breese GR
Psychopharmacologia; 1973 Jul; 31(2):95-109. PubMed ID: 4722209
[No Abstract] [Full Text] [Related]
6. Inhibition of tyrosine hydroxylase but not dopamine-beta-hydroxylase facilitates the action of behaviourally ineffective doses of neuroleptics.
Antelman SM; Szechtman H; Chin P; Fisher AE
J Pharm Pharmacol; 1976 Jan; 28(1):66-8. PubMed ID: 6656
[No Abstract] [Full Text] [Related]
7. Release of ( 3 H)noradrenaline and ( 3 H)dopamine from field stimulated cerebral cortex slices. Effect of tyrosine hydroxylase and dopamine- -hydroxylase inhibition.
Farnebo LO; Hamberger B; Jonsson G
J Neurochem; 1971 Dec; 18(12):2491-500. PubMed ID: 4400156
[No Abstract] [Full Text] [Related]
8. Role of brain noradrenaline in morphine-induced stereotyped behaviour.
Ayhan IH; Randrup A
Psychopharmacologia; 1972; 27(3):203-12. PubMed ID: 4674514
[No Abstract] [Full Text] [Related]
9. Minor tranquillizers, stress and central catecholamine neurons.
Corrodi H; Fuxe K; Lidbrink P; Olson L
Brain Res; 1971 Jun; 29(1):1-16. PubMed ID: 5564261
[No Abstract] [Full Text] [Related]
10. Evidence for a noradrenergic and dopaminergic mechanism in the hyperactivity produced by 4, alpha-dimethyl-m-tyramine (H 77-77) in rats.
Lassen JB
Psychopharmacologia; 1974; 37(4):331-40. PubMed ID: 4136728
[No Abstract] [Full Text] [Related]
11. A new dopamine- -hydroxylase inhibitor: effects on the noradrenaline concentration and on the action of L-DOPA in the spinal cord.
Andén NE; Fuxe K
Br J Pharmacol; 1971 Dec; 43(4):747-56. PubMed ID: 4339882
[TBL] [Abstract][Full Text] [Related]
12. Effect of neuroleptics on endogenous norepinephrine in rat brain.
Bartholini G; Keller HH; Pletscher A
Neuropharmacology; 1973 Aug; 12(8):751-6. PubMed ID: 4746440
[No Abstract] [Full Text] [Related]
13. Specific antagonism by dopamine inhibitors of items of amphetamine induced aggressive behaviour.
Hasselager E; Rolinski Z; Randrup A
Psychopharmacologia; 1972; 24(4):485-95. PubMed ID: 5064290
[No Abstract] [Full Text] [Related]
14. Central catecholamine neurons, behavior and neuroleptic drugs: an analysis to understand the involvement of catecholamines in schizophrenia.
Fuxe K; Nyström M; Tovi M; Smith R; Ogren SO
J Psychiatr Res; 1974; 11():151-61. PubMed ID: 4156786
[No Abstract] [Full Text] [Related]
15. Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
Khalsa JH; Davis WM
J Pharmacol Exp Ther; 1977 Jul; 202(1):182-91. PubMed ID: 17725
[No Abstract] [Full Text] [Related]
16. Inhibition of catecholamine synthesis during ontogenic development.
Kellogg C; Lundborg P
Brain Res; 1973 Oct; 61():321-9. PubMed ID: 4149305
[No Abstract] [Full Text] [Related]
17. The effect of dopamine and noradrenaline antagonists on amphetamine induced locomotor activity in mice and rats.
Rolinski Z; Scheel-Krüger J
Acta Pharmacol Toxicol (Copenh); 1973; 33(5):385-99. PubMed ID: 4149038
[No Abstract] [Full Text] [Related]
18. Differential effects on mouse brain catecholamine turnover of chlorpromazine, trifluoperazine and closely-related non-tranquillizing analogues.
Green AL
J Pharm Pharmacol; 1973 Mar; 25(3):267-9. PubMed ID: 4146333
[No Abstract] [Full Text] [Related]
19. Reversal by L-DOPA of the suppression of locomotor activity induced by inhibition of tyrosine-hydroxylase and DA-beta-hydroxylase in mice.
Ahlenius S
Brain Res; 1974 Mar; 69(1):57-65. PubMed ID: 4150408
[No Abstract] [Full Text] [Related]
20. Amfonelic acid, a non-amphetamine stimulant, has marked effects on brain dopamine metabolism but not noradrenaline metabolism: association with differences in neuronal storage systems.
McMillen BA; Shore PA
J Pharm Pharmacol; 1978 Jul; 30(7):464-6. PubMed ID: 27622
[No Abstract] [Full Text] [Related]
[Next] [New Search]
